(Q34546011)

English

Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

anti-retroviral agent

0 references

8

object named as

Amanda Mocroft

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Daniel Podzamczer

17

object named as

Daniel Podzamczer

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Geneviève Chêne

11

object named as

Geneviève Chêne

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

16

object named as

Caroline Sabin

0 references

Antonella d'Arminio Monforte

15

object named as

Antonella D'Arminio Monforte

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gerd Fätkenheuer

18

object named as

Gerd Fätkenheuer

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dominique Costagliola

12

object named as

Dominique Costagliola

0 references

Schlomo Staszewski

19

object named as

Schlomo Staszewski

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

object named as

Margaret May

5

0 references

Michael J Mugavero

14

object named as

Michael J Mugavero

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

object named as

Fiona Lampe

10

1 reference

ORCID Public Data File 2021

7

object named as

Amy Justice

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jonathan Sterne

21

object named as

Jonathan A C Sterne

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

9

object named as

Peter Reiss

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

David M Moore

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ross Harris

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Viviane Lima

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Bob Hogg

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Benita Yip

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Luigia Elzi

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

John Gill

20

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Antiretroviral Therapy Cohort Collaboration

22

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Journal of Acquired Immune Deficiency Syndromes

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

357-363

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

7 July 2018

Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

7 July 2018

Review: immunologic response to protease inhibitor-based highly active antiretroviral therapy: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

7 July 2018

Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

7 July 2018

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

7 July 2018

Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

7 July 2018

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Factors associated with poor immunologic responses despite viral suppression in markedly immunosuppressed patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

CD4(+) cell count increase predicts clinical benefits in patients with advanced HIV disease and persistent viremia after 1 year of combination antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Update on Department of Health and Human Services guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Suppression of plasma virus load below the detection limit of a human immunodeficiency virus kit is associated with longer virologic response than suppression below the limit of quantitation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

27 October 2018

Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3032437

9 December 2018

The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19668084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997

1 reference

https://pubmed.ncbi.nlm.nih.gov/19668084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Naive CD4+ Count in HIV-1-infected Patients at Time of Initiation of Highly Active Antiretroviral Therapy is Strongly Associated with the Level of Immunological Recovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/19668084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19668084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19668084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19668084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response

1 reference

https://pubmed.ncbi.nlm.nih.gov/19668084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19668084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/QAI.0B013E3181B62933

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34546011&oldid=1751777014"